Kevin Harrington, Professor in Biological Cancer Therapies at Institute of Cancer Research, shared a post on LinkedIn:
“How are emerging therapies reshaping the treatment of head and neck squamous cell carcinoma?
At the 2026 ASCO Annual Meeting, I will have the pleasure of joining Barbara Burtness and Aarti Bhatia for a CME symposium focused on innovation in HNSCC.
Taking place on Friday, May 29 at 7:00 PM CDT in Chicago or virtually, this PeerView live symposium will review the latest evidence on immunotherapy in both locally advanced and recurrent/metastatic settings, and explore emerging therapeutic strategies, including bispecific antibodies. We will also discuss practical approaches to improving outcomes for patients who have received prior therapies.
Other articles featuring Kevin Harrington on OncoDaily.